The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study

Autor: Spirtos, Nick M., Enserro, Danielle, Homesley, Howard D., Gibbons, Susan K., Cella, David, Morris, Robert T., DeGeest, Koen, Lee, Roger B., Miller, David S.
Zdroj: In Gynecologic Oncology July 2019 154(1):13-21
Databáze: ScienceDirect
Externí odkaz: